Munich Reinsurance Co Stock Corp in Munich trimmed its position in Lam Research Corporation (NASDAQ:LRCX – Free Report) by 10.6% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 42,175 shares of the semiconductor company’s stock after selling 4,976 shares during the quarter. Munich Reinsurance Co Stock Corp in Munich’s holdings in Lam Research were worth $18,276,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Norges Bank bought a new position in shares of Lam Research during the 4th quarter worth approximately $3,645,427,000. Price T Rowe Associates Inc. MD boosted its position in Lam Research by 352.2% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 13,695,210 shares of the semiconductor company’s stock worth $2,344,347,000 after purchasing an additional 10,666,540 shares during the period. Franklin Resources Inc. increased its holdings in shares of Lam Research by 57.0% in the fourth quarter. Franklin Resources Inc. now owns 10,110,560 shares of the semiconductor company’s stock valued at $1,730,724,000 after purchasing an additional 3,671,073 shares during the last quarter. Corient Private Wealth LLC raised its position in shares of Lam Research by 235.5% in the fourth quarter. Corient Private Wealth LLC now owns 5,199,441 shares of the semiconductor company’s stock valued at $890,040,000 after purchasing an additional 3,649,553 shares during the period. Finally, J. Stern & Co. LLP lifted its stake in shares of Lam Research by 3,826.9% during the 4th quarter. J. Stern & Co. LLP now owns 3,459,377 shares of the semiconductor company’s stock worth $592,176,000 after buying an additional 3,371,283 shares during the last quarter. Institutional investors own 84.61% of the company’s stock.
Insider Transactions at Lam Research
In other news, Director Abhijit Y. Talwalkar sold 18,282 shares of the stock in a transaction dated Monday, July 13th. The shares were sold at an average price of $335.00, for a total value of $6,124,470.00. Following the completion of the transaction, the director owned 87,142 shares of the company’s stock, valued at approximately $29,192,570. This represents a 17.34% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Eric Brandt sold 54,500 shares of the company’s stock in a transaction that occurred on Thursday, June 11th. The stock was sold at an average price of $350.80, for a total transaction of $19,118,600.00. Following the transaction, the director owned 199,205 shares of the company’s stock, valued at approximately $69,881,114. This represents a 21.48% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 80,441 shares of company stock valued at $27,614,296. 0.31% of the stock is currently owned by insiders.
Lam Research Price Performance
Lam Research (NASDAQ:LRCX – Get Free Report) last posted its quarterly earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 EPS for the quarter, topping analysts’ consensus estimates of $1.69 by $0.13. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.The company had revenue of $6.72 billion during the quarter, compared to analysts’ expectations of $6.66 billion. During the same quarter in the previous year, the firm earned $1.33 EPS. Lam Research’s revenue was up 30.0% on a year-over-year basis. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. Equities analysts expect that Lam Research Corporation will post 9.32 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
A number of brokerages recently commented on LRCX. B. Riley Financial decreased their price target on shares of Lam Research from $385.00 to $350.00 and set a “buy” rating on the stock in a research note on Thursday, July 30th. Rothschild & Co Redburn increased their target price on Lam Research from $305.00 to $420.00 and gave the stock a “buy” rating in a research note on Wednesday, June 17th. Zacks Research upgraded Lam Research from a “hold” rating to a “strong-buy” rating in a research note on Friday, July 17th. Weiss Ratings raised Lam Research from a “buy (b-)” rating to a “buy (b)” rating in a report on Friday. Finally, Seaport Research Partners initiated coverage on Lam Research in a research report on Monday, May 4th. They set a “buy” rating and a $300.00 price objective on the stock. One investment analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $358.47.
View Our Latest Report on Lam Research
Lam Research Profile
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Featured Stories
- Five stocks we like better than Lam Research
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
